# Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)

> **NCT02720107** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 133 (actual)

## Conditions studied

- Relapsing-remitting Multiple Sclerosis

## Interventions

- **DRUG:** fingolimod

## Key facts

- **NCT ID:** NCT02720107
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-12
- **Primary completion:** 2016-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720107

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720107, "Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02720107. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*